Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Risk Assessment for Inherited Susceptibility to Cancer: A Review of the Psychosocial and Ethical Dimensions
2005
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
2015
Breast cancer
2019 Standout
Macrophages orchestrate breast cancer early dissemination and metastasis
2017
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
Triple-Negative Breast Cancer
2010 Standout
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres
2010 Standout
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
2013 Standout
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
2011
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Breast cancer
2016 Standout
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy
2017
Contribution of platelets to tumour metastasis
2011 Standout
Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients
2016
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Breast cancer cell response to genistein is conditioned by BRCA1 mutations
2009
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
2012
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Relationship Between Clinical and Pathologic Features of Ductal Carcinoma In Situ and Patient Age
2009
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: A systematic review
2009
Emerging Biological Principles of Metastasis
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Microenvironmental regulation of metastasis
2008 Standout
How smart do biomaterials need to be? A translational science and clinical point of view
2012
Barriers and facilitators to implementing shared decision-making in clinical practice: Update of a systematic review of health professionals’ perceptions
2008 Standout
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer
2013 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer Patients
2009
Systemic Spread Is an Early Step in Breast Cancer
2008
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
2015
Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)
2010
The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer
2012
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Axillary Nodal Management Following Neoadjuvant Chemotherapy
2016
Nanomaterials for In Vivo Imaging
2017
Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery
2014
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Diabetes and Cancer
2010 Standout
Breast Cancer Treatment
2019 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
2007
The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer
2013
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
2016
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Obesity and Cancer: The Role of Dysfunctional Adipose Tissue
2009
Works of S. Giard being referenced
Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience
2009
Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial
2014
Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients
2001
Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers’ experience
2002
Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases
2013
Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo-adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process? Experience in 56 Patients Treated in a Single Institution
2010
Partial breast irradiation as sole therapy for low risk breast carcinoma: Early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study
2008
Alerte sanitaire et implants mammaires PIP : expérience du centre régional de lutte contre le cancer de Lille
2012
Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: The French Sentimag feasibility trial
2016
Sentinel node biopsy versus complete axillary clearance in breast cancer: The patients' point of view. Results of a prospective survey
2004
Messenger RNA Expression of Leptin and Leptin Receptors and their Prognostic Value in 322 Human Primary Breast Cancers
2006
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study
2008
[A prospective evaluation of antibiotic prophylaxis efficacy for breast cancer surgery following previous chemotherapy].
2004
[Attitudes towards screening and prevention of breast and ovarian cancers with hereditary predisposition. Survey by female gynecologists in the north of France].
1996